|
Q1 FY2027
As of Jun 30, 2026
|
Q4 FY2026
As of Mar 31, 2026
|
Q3 FY2026
As of Dec 31, 2025
|
Q2 FY2026
As of Sep 30, 2025
|
Q1 FY2026
As of Jun 30, 2025
|
Q4 FY2025
As of Mar 31, 2025
|
Q3 FY2025
As of Dec 31, 2024
|
Q2 FY2025
As of Sep 30, 2024
|
Q1 FY2025
As of Jun 30, 2024
|
Q4 FY2024
As of Mar 31, 2024
|
Q3 FY2024
As of Dec 31, 2023
|
Q2 FY2024
As of Sep 30, 2023
|
Q1 FY2024
As of Jun 30, 2023
|
Q4 FY2023
As of Mar 31, 2023
|
Q3 FY2023
As of Dec 31, 2022
|
Q2 FY2023
As of Sep 30, 2022
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||||||
| Investments at fair value | ||||||||||||||||
| Non-Control/Non-Affiliate Investments | ||||||||||||||||
| Affiliate Investments | ||||||||||||||||
| Control Investments | ||||||||||||||||
| Total investments at fair value | ||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||
| Restricted cash and cash equivalents | ||||||||||||||||
| Cash | ||||||||||||||||
| Cash equivalents | ||||||||||||||||
| Restricted cash | ||||||||||||||||
| Interest receivable | ||||||||||||||||
| Due from administrative agent | ||||||||||||||||
| Deferred financing costs, net | ||||||||||||||||
| Other assets, net | ||||||||||||||||
| TOTAL ASSETS | ||||||||||||||||
| LIABILITIES | ||||||||||||||||
| Borrowings: | ||||||||||||||||
| Line of credit at fair value (Cost of $157,600 and $23,900, respectively) | ||||||||||||||||
| Notes payable, net of unamortized deferred financing costs of $7,815 and $8,460, respectively | ||||||||||||||||
| Total borrowings | ||||||||||||||||
| Accounts payable and accrued expenses | ||||||||||||||||
| Interest payable | ||||||||||||||||
| Fees due to related party | ||||||||||||||||
| Distributions payable | ||||||||||||||||
| Other liabilities | ||||||||||||||||
| TOTAL LIABILITIES | ||||||||||||||||
| NET ASSETS | ||||||||||||||||
| ANALYSIS OF NET ASSETS | ||||||||||||||||
| Common stock, $0.001 par value per share, 100,000,000 shares authorized, 39,821,967 and 39,821,967 shares issued and outstanding, respectively | ||||||||||||||||
| Capital in excess of par value | ||||||||||||||||
| Cumulative net unrealized appreciation of investments | ||||||||||||||||
| Cumulative net unrealized depreciation of other | ||||||||||||||||
| Cumulative net unrealized appreciation of other | ||||||||||||||||
| Overdistributed net investment income | ||||||||||||||||
| Accumulated net realized gain in excess of distributions | ||||||||||||||||
| Accumulated net realized (loss) gain in excess of distributions | ||||||||||||||||
| Total distributable earnings | ||||||||||||||||
| TOTAL NET ASSETS | ||||||||||||||||
| NET ASSET VALUE PER SHARE (in USD per share) | ||||||||||||||||
Loading...
